Align Technology reported $72.48M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
3M USD 532.63M 523.63M Jun/2025
Align Technology USD 72.48M 572K Jun/2025
Becton, Dickinson and Co. USD 370.59M 406K Jun/2025
Bruker USD 151.72M 149.92M Jun/2025
Cardinal Health USD 239M 2.71B Jun/2025
Charles River Laboratories USD 49.21M 48.7M Jun/2025
Cooper Companies USD 198.8M 177M Jul/2025
CVS Health USD 1.27B 48.57B Jun/2025
Danaher USD 715.9M 706.9M Jun/2025
Dentsply International USD 199.3M 196.3M Jun/2025
Dexcom USD 392.2M 391.8M Jun/2025
Henry Schein USD 121.9M 120.9M Jun/2025
Idexx Laboratories USD 80.42M 63.77M Jun/2025
Insulet USD 70.39M 70.29M Jun/2025
Integra LifeSciences USD 77.92M 77M Jun/2025
IQVIA Holdings USD 170M 167.42M Jun/2025
Masimo USD 54.3M 54.2M Jun/2025
McKesson USD 280M 277M Jun/2025
Mettler Toledo International USD 20.6M 20.15M Jun/2025
Revvity USD 117.87M 2.78M Jun/2025
Solventum Corp 173.39M 171.39M Jun/2025
Stryker USD 382.3M 344.3M Jun/2025
Teleflex USD 44.19M 4M Jun/2025
Thermo Fisher Scientific USD 377.49M 66.51M Jun/2025
Veeva Systems USD 163.88M 903K Jul/2025
Waters USD 59.51M 57.88M Jun/2025
Zimmer Biomet Holdings USD 197.9M 194.7M Jun/2025
Zoetis USD 443.95M 438.95M Jun/2025